Stryker Corporation (LON:0R2S)
London
· Delayed Price · Currency is GBP · Price in USD 382.92
+4.38 (1.16%)
At close: Aug 15, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Instruments | 2.83B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Instruments Growth | 9.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Endoscopy | 3.39B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Endoscopy Growth | 12.99% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical | 3.85B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Growth | 11.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Knees | 2.45B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Knees Growth | 8.61% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hips | 1.70B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hips Growth | 12.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Trauma and Extremities | 3.51B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Trauma and Extremities Growth | 14.45% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Spinal Implants | 707.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Spinal Implants Growth | -19.49% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Orthopaedics | 712.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Orthopaedics Growth | 6.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Neurovascular | 1.31B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Neurovascular Growth | 24.13% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Neuro Cranial | 2.14B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Neuro Cranial Growth | 17.19% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| MedSurg & Neurotechnology Operating Income | 4.00B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| MedSurg & Neurotechnology Operating Income Growth | 14.82% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Orthopaedics Operating Income | 2.59B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Orthopaedics Operating Income Growth | 16.38% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| United States | 16.94B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 12.39% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International | 5.65B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International Growth | 8.31% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Organic Net Sales Growth | 10.20% |
Log In |
Log In |
Log In |
Log In | Upgrade
|